Organon & Co
907 hedge funds and large institutions have $5.51B invested in Organon & Co in 2021 Q4 according to their latest regulatory filings, with 149 funds opening new positions, 214 increasing their positions, 415 reducing their positions, and 155 closing their positions.
3.52% more ownership
Funds ownership: 68.14% → 71.66% (+3.5%)
5% more call options, than puts
Call options by funds: $34M | Put options by funds: $32.4M
3% less capital invested
Capital invested by funds: $5.67B → $5.51B (-$158M)
4% less first-time investments, than exits
New positions opened: 149 | Existing positions closed: 155
2% less funds holding
Funds holding: 928 → 907 (-21)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
48% less repeat investments, than reductions
Existing positions increased: 214 | Existing positions reduced: 415
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$98.7M |
| 2 |
MAMU
Marathon Asset Management (UK)
London,
United Kingdom
|
+$80.4M |
| 3 |
Janus Henderson Group
London,
|
+$59.6M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$43.9M |
| 5 |
SSM
Sound Shore Management
Greenwich,
Connecticut
|
+$30.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$40.9M |
| 2 |
GCM
Glenview Capital Management
New York
|
-$24.7M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$24M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$18.5M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$17.4M |
OGN Hedge Fund Activity: Q4 2021 in Review
907 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q4 2021, worth a combined $5.51B — down 2.8% from $5.67B a quarter earlier.
Sellers outnumbered buyers: 155 funds closed out of OGN and 149 opened new positions — a net loss of 6 holders — while 415 trimmed existing stakes and 214 added.
The largest buyer was Bank of New York Mellon, adding an estimated $98.7M. The largest seller was Wellington Management Group, cutting an estimated $40.9M.
- 907 institutional investors held Organon & Co (OGN) as of Q4 2021, down from 928 in Q3 2021.
- Funds reported $5.51B of Organon & Co stock for Q4 2021, down 2.8% quarter-over-quarter.
- 149 funds opened new Organon & Co positions in Q4 2021 and 155 closed out, a net change of -6 holders.
- The largest Organon & Co buyer in Q4 2021 was Bank of New York Mellon, an estimated $98.7M added.
- The largest Organon & Co seller in Q4 2021 was Wellington Management Group, an estimated $40.9M sold.
Based on aggregated 13F filings for Q4 2021.